These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7102262)

  • 1. Dantrolene sodium in chronic spasticity of varying etiology. A double-blind study.
    Luisto M; Möller K; Nuutila A; Palo J
    Acta Neurol Scand; 1982 Apr; 65(4):355-62. PubMed ID: 7102262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment with dantrolene sodium of stroke patients with spasticity limiting the return of function.
    Ketel WB; Kolb ME
    Curr Med Res Opin; 1984; 9(3):161-9. PubMed ID: 6499510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of dantrolene sodium in the treatment of spasticity.
    Chipman M; Kaul S; Lambie M
    Dis Nerv Syst; 1974 Sep; 35(9):427-31. PubMed ID: 17894068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jan; 13(1):3-23. PubMed ID: 318989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of spasticity with tizanidine in multiple sclerosis.
    Lapierre Y; Bouchard S; Tansey C; Gendron D; Barkas WJ; Francis GS
    Can J Neurol Sci; 1987 Aug; 14(3 Suppl):513-7. PubMed ID: 3676923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Objective assessment of spasticity, strength, and function with early exhibition of dantrolene sodium after cerebrovascular accident: a randomized double-blind study.
    Katrak PH; Cole AM; Poulos CJ; McCauley JC
    Arch Phys Med Rehabil; 1992 Jan; 73(1):4-9. PubMed ID: 1729971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of dantrolene sodium in spasticity with low dependence on fusimotor drive.
    Knutsson E; Martensson A
    J Neurol Sci; 1976 Oct; 29(2-4):195-212. PubMed ID: 135820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dantrolene sodium and diazepam in the treatment of spasticity.
    Schmidt RT; Lee RH; Spehlmann R
    J Neurol Neurosurg Psychiatry; 1976 Apr; 39(4):350-6. PubMed ID: 778344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dantrolene sodium on the incidence of seizures in children with spasticity.
    Nogen AG
    Childs Brain; 1979; 5(4):420-5. PubMed ID: 378580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review.
    Montané E; Vallano A; Laporte JR
    Neurology; 2004 Oct; 63(8):1357-63. PubMed ID: 15505149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease.
    Weiser R; Terenty T; Hudgson P; Weightman D
    Practitioner; 1978 Jul; 221(1321):123-7. PubMed ID: 366589
    [No Abstract]   [Full Text] [Related]  

  • 12. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.
    Ward A; Chaffman MO; Sorkin EM
    Drugs; 1986 Aug; 32(2):130-68. PubMed ID: 3527659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.
    Gracies JM; Nance P; Elovic E; McGuire J; Simpson DM
    Muscle Nerve Suppl; 1997; 6():S92-120. PubMed ID: 9826984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tizanidine treatment of spasticity caused by multiple sclerosis: results of a double-blind, placebo-controlled trial. US Tizanidine Study Group.
    Smith C; Birnbaum G; Carter JL; Greenstein J; Lublin FD
    Neurology; 1994 Nov; 44(11 Suppl 9):S34-42; discussion S42-3. PubMed ID: 7970009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dantrolene sodium: long-term effects in patients with muscle spasticity.
    Joynt RL
    Arch Phys Med Rehabil; 1976 May; 57(5):212-7. PubMed ID: 776122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of spasticity with dantrolene sodium].
    Winnem M
    Tidsskr Nor Laegeforen; 1980 Oct; 100(29):1727-8. PubMed ID: 7008246
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis.
    Smolenski C; Muff S; Smolenski-Kautz S
    Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene sodium suspension in treatment of spastic cerebral palsy.
    Joynt RL; Leonard JA
    Dev Med Child Neurol; 1980 Dec; 22(6):755-67. PubMed ID: 7004956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of tizanidine in the treatment of spasticity caused by multiple sclerosis. United Kingdom Tizanidine Trial Group.
    Neurology; 1994 Nov; 44(11 Suppl 9):S70-8. PubMed ID: 7970014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM; Brashear A; Jech R; McAllister P; Banach M; Valkovic P; Walker H; Marciniak C; Deltombe T; Skoromets A; Khatkova S; Edgley S; Gul F; Catus F; De Fer BB; Vilain C; Picaut P;
    Lancet Neurol; 2015 Oct; 14(10):992-1001. PubMed ID: 26318836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.